← Back to Search

Cannabinoid

CBD for Chronic Pain

Phase < 1

Recruiting

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Chronic musculoskeletal and joint pain for at least 3 months or longer

Age between 18-50 yrs

Must not have

Current or past neurological illness

Type I and type II diabetes

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 days

Summary

This trial will investigate whether CBD can help relieve chronic pain.

Who is the study for?

This trial is for adults aged 18-50 who have been experiencing chronic musculoskeletal and joint pain for at least three months. Participants need to live within a 60-mile radius of Salt Lake City, Utah.

What is being tested?

The study is testing the effects of Cannabidiol (CBD), a compound found in cannabis plants, against a placebo to understand how CBD might alleviate chronic non-cancer pain.

What are the potential side effects?

While not explicitly listed here, common side effects of CBD may include tiredness, diarrhea, changes in appetite/weight. However, individual experiences with side effects can vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had joint or muscle pain for 3 months or more.

Select...

I am between 18 and 50 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a history of neurological illness.

Select...

I have diabetes.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Neurochemical Brain Changes

Secondary study objectives

Pain Improvement

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: CannabidiolActive Control1 Intervention

Drug: Cannabidiol An oral dose of Cannabidiol (CBD) will be given once a day for five day with pain ratings taken before and after each dose every day. Other Names: CBD

Group II: PlaceboPlacebo Group1 Intervention

Drug: Placebos An oral placebo will be given once a day for five day with pain ratings taken before and after each dose every day. Other Names: placebo

0 / 4Eligibility criteria met